CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced today that it will be presenting at the 6th Annual Metabolic Diseases Drug Discovery and Development World Summit in San Diego, California. Jill Milne, Ph.D., Senior Director of Biology at Sirtris, will deliver a keynote address “SIRT1 Activation: A Novel Mechanism for Treating Type 2 Diabetes.” Her presentation is scheduled to be delivered at 8:45 am PST on Tuesday, July 17, 2007.
